Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study
详细信息 查看全文
- 作者：Ayong Cao ; Jin Zhang ; Xiaoan Liu ; Weizhu Wu…
- 关键词：Quality of life ; Prospective ; Functional Assessment of Cancer Therapy ; Breast ; Trial outcome index ; Hormone receptor ; positive early ; stage breast cancer postmenopause ; Adjuvant ; Aromatase inhibitors ; Early breast cancer
- 刊名：Health and Quality of Life Outcomes
- 出版年：2016
- 出版时间：December 2016
- 年：2016
- 卷：14
- 期：1
- 全文大小：477 KB
- 刊物主题：Quality of Life Research; Quality of Life Research;
- 出版者：BioMed Central
- ISSN：1477-7525
文摘
Background Estimating quality of life (QoL) in patients with breast cancer is of importance in assessing treatment outcomes. Adjuvant endocrine therapy is widely used for hormone receptor-positive (HR+) early-stage breast cancer (EBC), and evidence suggests that aromatase inhibitors (AIs) may improve QoL for these patients. This study evaluated QoL in postmenopausal Chinese patients with HR+ EBC taking AIs.